Small labeling changes to phenytoin unit dose cup causes confusion

August 12, 2010 issue of the ISMO Medication Safety Alert the issue of : “We have received a number of reports about the labeling of Xactdose unit dose liquid containers from VistaPharm, Inc., of Birmingham, AL. The company recently changed the way the drug concentrations are expressed on their labels. An example is phenytoin oral suspension which went from emphasizing 100 mg/4 mL to listing 125 mg/5 mL. The company rightly notes that the 125 mg/5 mL container delivers 100 mg or 4 mL (due to the heavy liquid consistency of phenytoin suspension), but the message doesn’t necessarily translate to nurses who are confused by the new label and need to give an exact dose. The good news is, we learned last week that VistaPharm is returning to the old style label. That will no doubt lead to less confusion, but nurses should also know not to rinse the residual suspension from the cup. Doing so would approximate as much as a 25% overdose. The company said they expect to release products with revised labeling by the end of the month.”

This ISMP Alert was perfectly timed because we had confusion over this labeling just a couple of weeks ago. I grabbed one of each label type out of the carousel and snapped a couple of pictures. See below. The top image is of the original labeling, the middle image is the new labeling and the bottom image is the two sitting side by side for comparison.

Liquid unit doses should really be packaged in an oral syringe. Oral syringes are clearly marked to indicate volume, which helps avoid confusion like that caused by unit dosed cup. Another thing I would like to see changed is the use of concentrations like 125mg/5mL and 100mg/4mL. Even though these concentrations are clearly the same, you wouldn’t believe how often this confuses people. Labeling should contain the concentrations in its lowest possible volume, i.e. 25mg/mL, and the dose should be clearly marked, i.e. dose = 100mg = 4mL.

Posted via email from fahrni's posterous

Comments

Math is SCARY

Math is SCARY

Biovailability Issues?

 

Isn't there some bioavailablity issues?  That is 100mg oral capsule dose is equal to 125mg of the suspension?

Related: I recall a study a consultant pharmacist did while I was a student (back in the stone age).  She showed much higher phenytoin levels, some in the toxic level, in nursing home patients near the end of the fill cycle of phenytion suspension Rx's.  Why?  Because the bottle was not shaken (or stirred) well.  The drug settled on the bottom and residents would get high doses as there was less in the bottle.  

In the pictures Shake Well does not exactly stand out in these labels. 

Shake well

Yeah, I worked LTC for about a year and it was a problem. That's why I said in the post that suspensions should be packed in syringes. When you push that plunger down the entire dose is forced from the syringe regardless of how well it's mixed.

As to the cap vs. suspension issue, it really doesn't matter in my opinion as long as you follow a level and are consistent, i.e. don't bounce between susp and oral.

With regards to getting all

With regards to getting all of the liquid out of a syringe vs a cup, I agree the syringe is superior.  

But if you draw a partial volume out of a container/cup that isn't shaken up, then you run the risk of the same sedimentation issue.  

 

Say you have a 5 ml dose cup, and you need to draw a 2 ml dose into a syringe.  If you don't shake the suspension in the cup before you draw it out, then you are no better than using the cup alone.  

Great story John. There may

Great story John.

There may very well be some bioavailability issues, but the fact that they labeled this as 125/5 and it is actually only 4 ml in the cup is horrible.